Woodline Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Buy |
+208,552
| New | +$31.6M | 0.17% | 176 |
|
|
2024
Q2 | – | Sell |
-16,780
| Closed | -$4.55M | – | 577 |
|
|
2024
Q1 | $4.55M | Buy |
+16,780
| New | +$4.55M | 0.04% | 368 |
|
|
2021
Q4 | – | Sell |
-12,426
| Closed | -$5.13M | – | 715 |
|
|
2021
Q3 | $5.13M | Sell |
12,426
-23,450
| -65% | -$9.68M | 0.08% | 244 |
|
|
2021
Q2 | $13.3M | Buy |
35,876
+4,140
| +13% | +$1.53M | 0.25% | 108 |
|
|
2021
Q1 | $9.2M | Buy |
31,736
+5,533
| +21% | +$1.6M | 0.2% | 125 |
|
|
2020
Q4 | $6.55M | Buy |
+26,203
| New | +$6.55M | 0.17% | 145 |
|